Skip to main content

Animations

MJFF Publications

8101 - 8125 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2020
  • 2017
  • 2025
  • 2023
  • 2023
  • 2020
  • 2023
  • 2023
  • 2023
  • 2025
  • 2015
  • 2023
  • 2009
  • 2019
  • 2017
  • 2015
  • 2025
  • 2010
  • 2010
  • 2018
  • 2023
  • 2017
  • 2019
  • Summary Details
    RESTRICTED
    Title: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: The Lysosome and Nonmotor Symptoms: Linking Parkinson's Disease and Lysosomal Storage Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28232
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27219
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Development of a highly potent and selective degrader of LRRK2
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2023.129449
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learning
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.047358
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells12040625
    Citation Count: 31
  • Summary Details
    OPEN
    Title: ZEBRA: a hierarchically integrated gene expression atlas of the murine and human brain at single-cell resolution
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkad990
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Decreased SNCA expression in whole-blood RNA analysis of Parkinson’s disease adjusting for neutrophils
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01062-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa
    DOI - Digital Object Identifier: 10.3233/jpd-150570
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Cognitive Predictors of Responsiveness to Reactive Step Training in People with Parkinson’s Disease at Fall-Risk
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137517
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.010
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
    Journal Name: Clinical Biochemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006
    Citation Count: 34
  • Summary Details
    OPEN
    Title: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2016-0366
    Citation Count: 52
  • Summary Details
    RESTRICTED
    Title: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-024-01104-6
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease
    Journal Name: Chest
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1378/chest.10-0342
    Citation Count: 88
  • Summary Details
    RESTRICTED
    Title: Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D2/D3 receptor blockade
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.01.014
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom13091303
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014
    Citation Count: 154
  • Summary Details
    OPEN
    Title: Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz164
    Citation Count: 51
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.